Back to MORGAN STANLEY MORGAN STANLEY

BCLIBCLI
4 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in BrainStorm Cell Therapeutics In

MORGAN STANLEY previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$9,800

Total Shares Change

-4,317

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Increased
5,803
+33.8%
$6,4990.0%$1.06
14
2025-Q1
Increased
4,338
+0.5%
$5,4660.0%$1.19
10
2024-Q4
New
4,317
-
$9,8000.0%$2.37
26

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used